| abstract |
The composition comprises (A) protamine or a derivative thereof and (B) tranexamic acid and / or epsilon aminocaproic acid, and the blending ratio of (A) component / (B) component is 0.05 to 20 by mass ratio. More preferably, the composition for oral cavity characterized by containing ascorbate, an ascorbic acid derivative or a salt thereof, and sodium fluoride. [Effect] The composition for oral cavity of the present invention effectively and remarkably suppresses inflammation caused by periodontal pathogens in the oral cavity, is highly safe to the human body, and is effective in the prevention and treatment of periodontal disease. . [Selection figure] None |